Amicus Therapeutics Inc (FOLD)
10.84
+0.23
(+2.17%)
USD |
NASDAQ |
Apr 22, 16:00
10.84
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Shareholders Equity (Quarterly): 160.17M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 160.17M |
September 30, 2023 | 133.24M |
June 30, 2023 | 111.58M |
March 31, 2023 | 102.57M |
December 31, 2022 | 123.05M |
September 30, 2022 | 132.56M |
June 30, 2022 | 173.42M |
March 31, 2022 | 238.62M |
December 31, 2021 | 307.37M |
September 30, 2021 | 376.63M |
June 30, 2021 | 213.91M |
March 31, 2021 | 250.90M |
December 31, 2020 | 286.38M |
September 30, 2020 | 320.27M |
June 30, 2020 | 360.95M |
March 31, 2020 | 402.59M |
December 31, 2019 | 476.42M |
September 30, 2019 | 548.27M |
June 30, 2019 | 600.06M |
March 31, 2019 | 451.67M |
December 31, 2018 | 342.91M |
September 30, 2018 | 410.95M |
June 30, 2018 | 561.90M |
March 31, 2018 | 521.62M |
December 31, 2017 | 352.85M |
Date | Value |
---|---|
September 30, 2017 | 409.68M |
June 30, 2017 | 266.89M |
March 31, 2017 | 310.78M |
December 31, 2016 | 360.15M |
September 30, 2016 | 336.56M |
June 30, 2016 | 334.24M |
March 31, 2016 | 311.63M |
December 31, 2015 | 347.83M |
September 30, 2015 | 378.76M |
June 30, 2015 | 328.90M |
March 31, 2015 | 104.01M |
December 31, 2014 | 122.18M |
September 30, 2014 | 43.28M |
June 30, 2014 | 36.31M |
March 31, 2014 | 31.08M |
December 31, 2013 | 45.75M |
September 30, 2013 | 26.49M |
June 30, 2013 | 39.56M |
March 31, 2013 | 53.34M |
December 31, 2012 | 69.22M |
September 30, 2012 | 76.76M |
June 30, 2012 | 73.17M |
March 31, 2012 | 80.78M |
December 31, 2011 | 29.59M |
September 30, 2011 | 36.79M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
102.57M
Minimum
Mar 2023
600.06M
Maximum
Jun 2019
279.95M
Average
250.90M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
TG Therapeutics Inc | 160.50M |
Geron Corp | 247.95M |
Vanda Pharmaceuticals Inc | 544.91M |
Fate Therapeutics Inc | 368.42M |
Editas Medicine Inc | 349.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 777.88M |
Total Liabilities (Quarterly) | 617.71M |
Debt to Equity Ratio | 2.422 |
Current Ratio | 2.881 |
Net Debt Paydown Yield | 0.02% |